- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 20.10. | Kestra Medical Technologies: Evercore-Einstufung treibt Aktie vorbörslich an | 1 | Investing.com Deutsch | ||
| 20.10. | Evercore ISI initiates Kestra Medical stock with outperform rating | 1 | Investing.com | ||
| 05.10. | Piper Sandler reiterates Kestra Medical stock rating on patent potential | 1 | Investing.com | ||
| 01.10. | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Earns Five-Star Rating on Newsweek's List of America's Greatest Mid-Market Companies | 2 | GlobeNewswire (USA) | ||
| 15.09. | Kestra Medical Revenue: Jumps 60% To $31 Million As Wearable Cardiac Device Company Raises FY2027 Guidance | 4 | pulse2.com | ||
| 15.09. | Piper Sandler reiterates Kestra Medical stock rating after results | 1 | Investing.com | ||
| KESTRA MEDICAL TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| 15.09. | Stifel reiterates Buy on Kestra Medical stock, cites strong growth | 2 | Investing.com | ||
| 15.09. | Stifel bestätigt Kaufempfehlung für Kestra Medical Aktie nach starkem Wachstum | - | Investing.com Deutsch | ||
| 14.09. | Transcript: Kestra Medical Techs Q1 2027 Earnings Conference Call | 1 | Benzinga.com | ||
| 14.09. | Earnings Call: Kestra Medical verfehlt Gewinnerwartung für Q1 - Aktie bricht nachbörslich ein | 2 | Investing.com Deutsch | ||
| 14.09. | Kestra Medical Aktie: Hoher Verlust überschattet starkes Umsatzwachstum | 1 | Investing.com Deutsch | ||
| 14.09. | KESTRA MEDICAL TECHNOLOGIES, LTD. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 14.09. | Kestra Medical Technologies, Ltd. GAAP EPS of -$0.75 misses by $0.13, revenue of $31M beats by $1.99M | 3 | Seeking Alpha | ||
| 14.09. | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results | 218 | GlobeNewswire (Europe) | KIRKLAND, Wash., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results... ► Artikel lesen | |
| 10.09. | KESTRA MEDICAL TECHNOLOGIES, LTD. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.09. | Kestra Medical beruft Daniel Finney zum neuen Leiter für Forschung und Entwicklung | 4 | Investing.com Deutsch | ||
| 10.09. | Kestra Medical names Daniel Finney VP of research & development | 2 | Investing.com | ||
| 10.09. | Kestra Medical Technologies, Ltd.: Kestra Names Daniel Finney Vice President of Research & Development | 400 | GlobeNewswire (Europe) | KIRKLAND, Wash., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, announced today that Daniel... ► Artikel lesen | |
| 31.08. | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies to Report First Quarter Fiscal 2027 Financial Results on September 14 | 1 | GlobeNewswire (USA) | ||
| 26.08. | Kestra Medical appoints Curtis Kopf as SVP of customer experience | 1 | Investing.com |
1 2 3 Weiter >>
41 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| HEARTFLOW | 57,82 | 0,00 % | Biotech Stocks At 52-Week Highs - Vaxcyte +31% On Phase 3 Results, InfuSystem, Illumina +7%, Charles River Laboratories +7%, HeartFlow +5% | SAN DIEGO (dpa-AFX) - The following biotech stocks reached a 52-week high on October 5, 2026, driven by key catalysts such as encouraging clinical research data.Vaxcyte Inc. (PCVX)Vaxcyte is... ► Artikel lesen | |
| LIFESTANCE HEALTH GROUP | 13,100 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Strong Second Quarter 2026 Financial Results and Raises Full Year Outlook | SCOTTSDALE, Ariz., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 58,38 | 0,00 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| NUWELLIS, INC | 5,370 | 0,00 % | Nuwellis: Interview With President And CEO Mike McCormick About Precision Fluid Management And Cardiorenal Care | ||
| SIEMENS HEALTHINEERS | 42,030 | +0,38 % | EQS-CMS: Siemens Healthineers AG: Veröffentlichung einer Kapitalmarktinformation | EQS Zulassungsfolgepflichtmitteilung: Siemens Healthineers AG
/ Bekanntmachung nach Art. 5 Abs. 1 lit. b), Abs. 3 der Verordnung (EU) Nr. 596/2014, zuletzt geändert durch die Verordnung... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 8,055 | 0,00 % | Needham initiates Alignment Healthcare stock rating at Hold | ||
| GENEDX | 62,63 | 0,00 % | GeneDx plans to add long-read genome sequencing to portfolio | ||
| BILLIONTOONE | 114,02 | 0,00 % | BillionToOne, Inc.: BillionToOne's Tissue-Free Northstar Response Demonstrates On-Par to Superior Cancer Treatment Monitoring vs. Tumor-Informed Assay, New Peer-Reviewed Study Finds | MENLO PARK, Calif., Oct. 07, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (Nasdaq: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are... ► Artikel lesen | |
| BETA BIONICS | 21,440 | +0,23 % | Truist reiterates Buy on Beta Bionics stock, $28 target on MINT | ||
| PROGYNY | 27,720 | 0,00 % | Progyny, Inc.: New Progyny Study Finds Significant Improvement in Menopause Symptoms Through Connected Care Model | ||
| FRESENIUS | 45,975 | -0,61 % | JEFFERIES stuft Fresenius SE auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat Fresenius auf "Buy" mit einem Kursziel von 55 Euro belassen. Die Gewinndynamik des Medizinkonzerns sollte sich im dritten Quartal fortgesetzt... ► Artikel lesen | |
| AVEANNA HEALTHCARE | 12,700 | 0,00 % | Biotech Stocks At 52-Week Highs - Park Dental Partners +10%, Aveanna Healthcare +24%, Candel Therapeutics +10% on Q2 Reports, Labcorp Holdings, Hemab Therapeutics | LONDON (dpa-AFX) - The following biotech stocks reached 52-week highs on August 13, 2026, driven by key catalysts such as positive quarterly reports and the issuance of increased guidance figures.Park... ► Artikel lesen | |
| CONCENTRA GROUP | 40,040 | 0,00 % | Biotech Stocks At 52-Week Highs - Retension Pharmaceuticals Rises With IPO, Biogen, Concentra Group, Hinge Health, HealthStream | WESTON (dpa-AFX) - The following biotech stocks reached a 52-week high on October 12, 2026, driven by catalysts such as achieving promising clinical data or a public offering.Biogen Inc. (BIIB)Biogen... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,310 | -0,64 % | Aktien Frankfurt Ausblick: Dax vor Rückkehr an sein Vortagshoch | FRANKFURT (dpa-AFX) - Der Dax dürfte am Mittwoch positiv ins Rennen gehen. Gut eine Stunde vor dem Auftakt signalisiert der X-Dax für den Dax einen 0,4 Prozent höheren Auftakt bei 25.399 Punkten. Damit... ► Artikel lesen |
Das Unternehmen KESTRA MEDICAL TECHNOLOGIES LTD kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 29,960 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu KESTRA MEDICAL TECHNOLOGIES LTD finden Sie auf Wallstreet Online.